J Wójcicki

1.2k total citations
75 papers, 955 citations indexed

About

J Wójcicki is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, J Wójcicki has authored 75 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 15 papers in Molecular Biology and 14 papers in Pharmacology. Recurrent topics in J Wójcicki's work include Drug-Induced Hepatotoxicity and Protection (16 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). J Wójcicki is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (16 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). J Wójcicki collaborates with scholars based in Poland, Czechia and United States. J Wójcicki's co-authors include L Samochowiec, B Gawrońska-Szklarz, Marek Droździk, L Roźéwicka, Barbara Wiszniewska, Zygmunt Juzyszyn, Aleksander Hinek, Mariola Marchlewicz, Monika Białecka and L Wenda-Rózewicka and has published in prestigious journals such as British Journal of Pharmacology, Atherosclerosis and Drug and Alcohol Dependence.

In The Last Decade

J Wójcicki

74 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Wójcicki Poland 15 196 187 180 163 148 75 955
T.C. Raghuram India 12 419 2.1× 192 1.0× 171 0.9× 94 0.6× 92 0.6× 24 1.1k
A. Esteller Spain 16 110 0.6× 83 0.4× 271 1.5× 223 1.4× 115 0.8× 66 1.2k
Haymie Choi South Korea 16 187 1.0× 223 1.2× 220 1.2× 217 1.3× 101 0.7× 40 995
D Weiser Germany 20 96 0.5× 146 0.8× 290 1.6× 208 1.3× 98 0.7× 80 1.1k
Surat Komindr Thailand 20 282 1.4× 285 1.5× 206 1.1× 95 0.6× 103 0.7× 53 1.1k
Florina Andrica Romania 12 181 0.9× 155 0.8× 167 0.9× 98 0.6× 206 1.4× 17 880
N. S. Parmar Saudi Arabia 17 83 0.4× 127 0.7× 208 1.2× 158 1.0× 65 0.4× 43 891
Jorgete Constantin Brazil 20 225 1.1× 83 0.4× 410 2.3× 127 0.8× 147 1.0× 65 1.2k
Mahmood Vessal Iran 18 388 2.0× 96 0.5× 280 1.6× 83 0.5× 200 1.4× 46 1.2k
Kristy L. West United States 14 270 1.4× 255 1.4× 209 1.2× 260 1.6× 230 1.6× 15 1.2k

Countries citing papers authored by J Wójcicki

Since Specialization
Citations

This map shows the geographic impact of J Wójcicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Wójcicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Wójcicki more than expected).

Fields of papers citing papers by J Wójcicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Wójcicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Wójcicki. The network helps show where J Wójcicki may publish in the future.

Co-authorship network of co-authors of J Wójcicki

This figure shows the co-authorship network connecting the top 25 collaborators of J Wójcicki. A scholar is included among the top collaborators of J Wójcicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Wójcicki. J Wójcicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wójcicki, J, et al.. (2003). Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects. Biopharmaceutics & Drug Disposition. 24(5). 211–218. 27 indexed citations
2.
Koytchev, Rossen, et al.. (2003). Evaluation of the efficacy of a combined formulation (Grippostad®-C) in the therapy of symptoms of common cold: a randomized, double-blind, multicenter trial. International Journal of Clinical Pharmacology and Therapeutics. 41(3). 114–125. 13 indexed citations
3.
Wójcicki, J, et al.. (2002). Comparison of MEGX (monoethylglycinexylidide) and antipyrine tests in patients with liver cirrhosis. European Journal of Drug Metabolism and Pharmacokinetics. 27(4). 243–247. 3 indexed citations
4.
Wójcicki, Maciej, Marek Droździk, Tadeusz Sulikowski, et al.. (2000). Pharmacokinetics of intravenously administered digoxin and histopathological picture in rabbits with experimental bile duct obstruction. European Journal of Pharmaceutical Sciences. 11(3). 215–222. 5 indexed citations
5.
Wójcicki, J, Wanda Górnik, Andrzej Pawlik, Marek Droździk, & B Gawrońska-Szklarz. (1996). Comparative Pharmacokinetics of Theophylline in Rabbits and in Humans with Hyperlipidemia. Pulmonary Pharmacology. 9(3). 175–178. 5 indexed citations
6.
Wójcicki, J, Anna Machoy‐Mokrzyńska, L Samochowiec, et al.. (1996). Effect of lecithin on the development of experimental atherosclerosis in rabbits. Phytomedicine. 2(3). 199–204. 1 indexed citations
7.
Wójcicki, J, Tadeusz Sulikowski, Maciej Wójcicki, et al.. (1996). Pharmacokinetics of phenazone (antipyrine) in rabbits with experimental common bile duct obstruction. British Journal of Pharmacology. 117(1). 1–4. 3 indexed citations
8.
Wójcicki, J, Tadeusz Sulikowski, Maciej Wójcicki, et al.. (1995). Pharmacokinetics of lidocaine and its major metabolite — monoethylglycinexylidide (MEGX) in rabbits with experimental common bile duct obstruction. European Journal of Drug Metabolism and Pharmacokinetics. 20(2). 119–123. 1 indexed citations
9.
Wójcicki, J. (1995). “J”-Index. A New Proposition of the Assessment of Current Glucose Control in Diabetic Patients. Hormone and Metabolic Research. 27(1). 41–42. 123 indexed citations
10.
Gawrońska-Szklarz, B, et al.. (1994). Effect of experimental hyperlipidemia on the pharmacokinetics of digoxin.. PubMed. 51(3). 271–4. 6 indexed citations
11.
Machoy‐Mokrzyńska, Anna, Igor Łoniewski, J Wójcicki, & L Samochowiec. (1992). Influence of pollen extracts on the central nervous system. Herba Polonica. 38(4). 189–194. 2 indexed citations
12.
Wójcicki, J, et al.. (1992). Essential phospholipids modify immunological functions and reduce experimental atherosclerosis in rabbits. Atherosclerosis. 93(1-2). 7–16. 6 indexed citations
13.
Wójcicki, J, et al.. (1991). The effect of pollen extracts on the endocrine function in rabbits. Herba Polonica. 37(37). 1 indexed citations
14.
Wójcicki, J, et al.. (1989). The influence of pollen extracts on biochemical disturbances in rats exposed to prolonged ethyl alcohol intake. Herba Polonica. 35(4). 1 indexed citations
15.
Samochowiec, L, et al.. (1989). The influence of pollen extracts on serum triglyceride lipase activity in rabbits on a high-fat diet. Herba Polonica. 35(1). 2 indexed citations
16.
Samochowiec, L & J Wójcicki. (1981). Effect of pollen on serum and liver lipids in rats fed on a high-lipid diet. Herba Polonica. 16 indexed citations
17.
Wójcicki, J, et al.. (1979). Comparative pharmacokinetics of paracetamol in men and women considering follicular and luteal phases.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29(2). 350–2. 32 indexed citations
18.
Wójcicki, J, et al.. (1979). The effect of a single dose of ethanol on pharmacokinetics of paracetamol.. PubMed. 30(6). 749–53. 4 indexed citations
19.
Wójcicki, J, et al.. (1977). A double-blind comparative evaluation of aspirin, paracetamol and paracetamol + caffeine (finimal) for their analgesic effectiveness.. PubMed. 25(2). 175–9. 19 indexed citations
20.
Wójcicki, J, et al.. (1972). Effect of Ethanol on Iron Absorption the Small Intestine of Rats. Quarterly Journal of Studies on Alcohol. 33(4). 958–961. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026